Codexis (CDXS) Competitors

Codexis (NASDAQ:CDXS) and Geron (NASDAQ:GERN) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

Do analysts prefer CDXS or GERN?

Codexis presently has a consensus price target of $11.00, indicating a potential upside of 291.46%. Geron has a consensus price target of $4.61, indicating a potential upside of 265.96%. Given Codexis' higher probable upside, equities research analysts plainly believe Codexis is more favorable than Geron.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Codexis	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Geron	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.60

Do institutionals & insiders believe in CDXS or GERN?

78.5% of Codexis shares are owned by institutional investors. Comparatively, 73.7% of Geron shares are owned by institutional investors. 2.1% of Codexis shares are owned by company insiders. Comparatively, 7.4% of Geron shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility & risk, CDXS or GERN?

Codexis has a beta of 2.52, indicating that its share price is 152% more volatile than the S&P 500. Comparatively, Geron has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500.

Does the media refer more to CDXS or GERN?

In the previous week, Geron had 9 more articles in the media than Codexis. MarketBeat recorded 10 mentions for Geron and 1 mentions for Codexis. Codexis' average media sentiment score of 1.87 beat Geron's score of 0.81 indicating that Codexis is being referred to more favorably in the media.

Company	Overall Sentiment
Codexis	Very Positive
Geron	Positive

Is CDXS or GERN more profitable?

Geron has a net margin of -119.54% compared to Codexis' net margin of -149.47%. Geron's return on equity of -47.86% beat Codexis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Codexis	-149.47%	-118.47%	-53.37%
Geron	-119.54%	-47.86%	-26.78%

Which has preferable earnings & valuation, CDXS or GERN?

Codexis has higher earnings, but lower revenue than Geron. Geron is trading at a lower price-to-earnings ratio than Codexis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Codexis	$59.35M	3.92	-$65.28M	-$0.99	-2.84
Geron	$76.99M	10.42	-$174.57M	-$0.21	-6.00

Summary

Geron beats Codexis on 11 of the 17 factors compared between the two stocks.